Abstract
AimMedical devices (medtech) is a strong driver of innovation and new treatments in healthcare. Straddling the fields of engineering and healthcare, successful medtech development demands critical needs assessment, highly skilled medical engineering professionals, and the successful collaboration between medical and other experts. Optimal development and testing need an efficient dialogue with third parties, including regulators and payers. BioInnovate Ireland was established in 2011 as a multidisciplinary, structured programme to shape the future of medical device therapy based on innovation and interdisciplinary cross-fertilisation.Methods and results107 fellows have completed the programme covering 20 clinical areas. Fellows have funded companies at a rate of more than 1.5 companies per year which have attracted Irish and international seed funding in excess of €40 million, excluding undisclosed investments.ConclusionsA multidisciplinary programme targeting mature, experienced professionals can drive a highly successful medtech start-up culture in the right ecosystem.
Reference18 articles.
1. Global EY . Pulse of the industry, 2019. Available: https://assets.ey.com/content/dam/ey-sites/ey-com/en_gl/topics/life-sciences/life-sciences-pdfs/ey-pulse-of-the-industry-2019.pdf [Accessed 24 September 2019].
2. Pietzsch JB , Shluzas LA , Paté-Cornell ME , et al . Stage-Gate process for the development of medical devices. J Med Device 2009;3:021004. doi:10.1115/1.3148836
3. The global MedTech hub: how Ireland is innovating for future healthcare and economic growth;Statement of Strategy,2016
4. BioInnovate. Available: https://www.bioinnovate.ie/how-we-do-it/fellowship.html
5. BioInnovate Ireland--fostering entrepreneurial activity through medical device innovation training;Bruzzi;Ann Biomed Eng,2013
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献